Clinical trials sponsored by Hudson Biotech

Phase breakdown

Conditions studied

Recruiting trials led by Hudson Biotech

• Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
  NCT07467447 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
  NCT07481747 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
  NCT07505745 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
  NCT07481734 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Hudson Biotech recruiting for?

Hudson Biotech is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.